Engin Altıntaşž

Profiles of serum microRNAs; miR-125b-5p and miR223-3p serve as novel biomarkers for HBV-positive hepatocellular carcinoma

Burcu GÜRER GİRAY, Gürol Emekdaş, Seda Tezcan et al. · Molecular Biology Reports · 2014 · 144 citations

Medicine, Molecular Biology, Oncology +15

Intralesional steroid injection in benign esophageal strictures resistant to bougie dilation

Engin Altıntaşž, Sabite Kaçar, Bilge Tunç et al. · Journal of Gastroenterology and Hepatology · 2004 · 115 citations

Medicine, Pharmacotherapy, Surgery +12

Guselkumab in Patients With Moderately to Severely Active Ulcerative Colitis: QUASAR Phase 2b Induction Study

Laurent Peyrin‐Biroulet, Jessica R. Allegretti, David T. Rubin et al. · Gastroenterology · 2023 · 92 citations · Full text

Pharmacy, Immunology, Pharmacotherapy +15

Oral Ritlecitinib and Brepocitinib for Moderate-to-Severe Ulcerative Colitis: Results From a Randomized, Phase 2b Study

William J. Sandborn, Silvio Danese, Jarosław Leszczyszyn et al. · Clinical Gastroenterology and Hepatology · 2023 · 89 citations

Pharmacy, Pharmacology, Pharmacotherapy +9

Guselkumab in patients with moderately to severely active ulcerative colitis (QUASAR): phase 3 double-blind, randomised, placebo-controlled induction and maintenance studies

David T. Rubin, Jessica R. Allegretti, Julián Panés et al. · The Lancet · 2024 · 83 citations · Full text

Pharmacy, Clinical Sciences, Pharmacotherapy +15